Page 2 - William Guyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hussman Strategic Advisors Inc. trimmed its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 32.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 63,000 shares of the biotechnology company’s stock after selling 30,600 shares during the period. Hussman Strategic […]

Operator: Good day. And welcome to the Corcept Therapeutics Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

Our readers share their opinions on a variety of topics